Table 3.
Infected cells per billion (IUPB) resting CD4+ T cells
| Patient | IUPB on HAART | IUPB on HAART | Interval (months) |
|---|---|---|---|
| 1 | 57 | 41 | 1 |
| 2 | 42 | 72 | 3 |
| 3 | 290 | 240 | 2 |
| 4 | 140 | 130 | 15 |
| 5 | 20 | 23 | 1 |
IUPB measurements from resting cell outgrowth assays on HAART prior to protocol therapy. Patient 5 was stably aviremic as per the entry criteria but did not receive T20 or VPA.